Robert Jones Bandage Versus Cast in the Treatment of Distal Radius Fracture in Children

December 4, 2023 updated by: Jagar Omar Doski, University of Duhok

Robert Jones Bandage Versus Cast in the Treatment of Distal Radius Fracture in Children: a Randomized Controlled Trial

Aim and objectives This study aimed to treat fractures of the distal end of the radius in the children with Robert Jones (RJ) bandage in comparison with a cast. The objective was to compare the frequency of occurrence of the complications, child comfortability, and family satisfaction with this treatment modality.

Study Overview

Status

Completed

Detailed Description

Methods Study type and approvals The study was a randomized controlled non-inferiority clinical trial of patients based on a parallel-group type with an allocation ratio of 1:1.

Sittings The study was done in the emergency reception unit and the orthopedic unit of Duhok Emergency Teaching Hospital (single-center study), Duhok city, Iraq during the period extending from October 2021 to August 2022.

The study was conducted by a team from the hospital composed of a consultant Orthopedic surgeon (person 1), a permanent resident orthopedic doctor (person 2), and a radiologist (person 3). Person 1 generates the random allocation sequence, assessed the outcome clinically, analyzed the results, and drafted the article. Person 2 enrolled the participants in the study, assigned the interventions, and drafted the article. Person 3 assessed the outcome radiologically.

Interventions The participants included received one of the modalities of treatment planned for this study. The first modality was by application of a short arm cast from just below the elbow to the finger's knuckles. The cast was from a Plaster of Paris bandage over a cotton pad. The participants received this modality of treatment considered as group 1 (control group). The second modality was the modified RJ bandage (firmly applied two layers of bulky cotton layers alternating with three layers of elastic bandage in the following order: bandage - cotton - bandage - cotton - bandage)[17]. It was applied from below the elbow to the finger's knuckles. The participants received this modality of treatment considered as group 2 (trial group).

The participants and their companions were instructed to keep their modality of treatment clean and dry. Both groups asked for frequent follow-up (at the end of the 2nd, 4th, 6th, and 12th week) until the fracture unit. At each follow-up visit, the participant was checked for possible complications. The final assessment was done at the end of the 12th week by the consultant orthopedic doctor in collaboration with the radiologist.

Sample size calculation The assumed sample size was calculated by using the G*Power 3.1.9.7 computer software program. A minimum of 148 participants (74 for each group) was required to have a power of 80% chance of detecting the difference between the groups, and a two-sided 95% level of confidence (0.05 level of significance) to avoid the type 1 -alpha- error, with a probable hypothetical effect size of about 0.3 and a degree of freedom of 1 in the contiguity table.

Randomization The allocation of the participants into the modalities of the treatment was done by a simple randomization method with an allocation ratio of 1:1. It was generated by using the website program www.randomization.com. The first generator of the program was used to randomize 148 subjects into both modalities of treatment blocks (74 casts, 74 RJ bandages) (seed 7180). The random allocation sequence was generated by person 1 from the team of the study. It was concealed from the rest of the study team. Person 2 enrolled the participants in the study (assessed the eligibility of the cases, obtained the informed consent) and assigned the interventions.

Blinding The team of the study (apart from person 3 - the radiologist) was not blinded to the modality of treatment that they provided to the patients. The radiologist who assessed the radiological outcome of the cases was blinded to the modalities of treatment. The participants were blinded to the result of the treatment of the other patients included in this study.

The data collection

The data was collected in a special paper for each patient separately. The data included were divided into two parts:

Part 1 included the basic demographic data of the patient and injury like name, age, gender, place of living, date of a wrist injury, type of wrist injury (proved by the radiographic film), type of treatment (group), the time interval between the injury and beginning of treatment, duration of treatment, dates of each follow up. Part 2 included the outcomes during each follow-up visit and at the final assessment like complications of treatment, patient comfortability, and family satisfaction.

Statistical analysis The data analysis was done by admitting the collected data into the Statistical Package for Social Sciences (SPSS) software computer program (IBM Corp. Released 2015. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.). The statistical analysis included the standard descriptive statistics used to describe the basic descriptive data of the patients and injuries. The means and standard deviations (SD) or medians and interquartile ranges were used for the continuous variables, while frequencies and percentages were used for the categorical variables. The comparison between the outcomes of the treatment modalities in both groups was done by finding the difference between the summary statistics in the chi-squared test. The difference was considered statistically significant when the p-value was less than 0.05.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Duhok Governorate / Kurdistan Region
      • Duhok, Duhok Governorate / Kurdistan Region, Iraq, 24001
        • Jagar Omar Doski

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 12 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: between 2-12 years old age.
  • Sex: both male and female.
  • Duration of symptoms: less than 5 days.
  • Type of injury: fracture at the distal end of radius proofed by a radiograph film in two views (posteroanterior and lateral).
  • Type of fracture: the fracture which is usually treated conservatively -without intervention- like:

    1. torus (buckle) metaphyseal fracture
    2. greenstick fracture
    3. undisplaced or minimal displaced fracture distal radial physis (Salter-Harris classification type 1 and 2 only) that does not need reduction
    4. undisplaced or minimal displaced metaphyseal fracture that doesn't need reduction (a tilt of fewer than 15 degrees and shift less than 5 millimeters at the fracture site in both views).

Exclusion Criteria:

  • open fractures
  • pathological fractures
  • displaced fractures that need reduction
  • delayed presentation beyond five days
  • associated fracture of the ulnar bone
  • polytraumatic cases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1
Cast by Plaster of Paris
Application of a short arm cast from just below the elbow to the finger's knuckles. The cast was from a Plaster of Paris bandage over a cotton pad. The participants who received this treatment modality were considered group 1 (control group)
Other Names:
  • Plaster of Paris
Experimental: Group 2
Robert Jones bandage
Modified RJ bandage (firmly applied two layers of bulky cotton layers alternating with two layers of elastic bandage in the following order: bandage - cotton - bandage - cotton - bandage). It was applied from below the elbow to the finger's knuckles. The participants who received this treatment modality were considered group 2 (trial group).
Other Names:
  • Crepe bandages plus cotton rolls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of complications
Time Frame: 6-12 weeks

The complications were considered to be present if one of the following was noticed:

  1. Skin problems like pressure soreness, skin irritation, itching, and dermatitis.
  2. Bone deformity due to a displacement of the bone fragments at the fracture site to an unacceptable degree (tilt more than 15 degrees and/or shift more than 50% of the bone width at the fracture site) confirmed by the report of the radiologist, or due to growth disturbance from growth plate damage.
  3. Joint stiffness by limitation of the wrist movements (limitation of more than 10 degrees in any direction).
  4. Refracture within 12 weeks.
6-12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child comfortability with the treatment modality.
Time Frame: 6 weeks
yes or no
6 weeks
Family satisfaction the treatment modality.
Time Frame: 6-12 weeks
yes or no
6-12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jagar O Doski, Ph.D., College of Medicine, University of Duhok, Duhok, Iraq.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2021

Primary Completion (Actual)

August 20, 2022

Study Completion (Actual)

August 21, 2022

Study Registration Dates

First Submitted

August 22, 2022

First Submitted That Met QC Criteria

August 25, 2022

First Posted (Actual)

August 30, 2022

Study Record Updates

Last Update Posted (Estimated)

December 11, 2023

Last Update Submitted That Met QC Criteria

December 4, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be provided by the authors on reasonable request.

IPD Sharing Time Frame

directly after publication of the article and whenever requested.

IPD Sharing Access Criteria

email: jagaromar@uod.ac

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children, Only

Clinical Trials on cast

Subscribe